This update (No. 111 | 29 December 2023) covers key EU regulatory developments related to the evolving situation concerning EU emergency responses to, in particular, COVID-19, Russia's war of aggression against Ukraine...

The Federal Law No. 180-FZ dated 23 June 2016 ‘On Biomedical Cell Products' is aimed at developing the sector of biomedical technologies in Russia.

On 29 July 2016, the Orders of the Ministry of Industry and Trade of the Russian Federation (Minpromtorg), dated 31 December 2015, entered into force that approved...

Federal Law No. 225-FZ on Amendments to Part Two of the Tax Code of the Russian Federation dated 30 June 2016 enters into force on 1 August 2016.

The UK Government has provided designers and manufacturers with protection from product liability claims which arise from new ventilators.

In this comprehensive report, now in its third edition, we present a detailed and current review of the trademark aspects of the pharmaceutical industry in Russia today – a market that ...

The Russian government has recently presented a new legislative initiative aimed at exercising stricter control over food additives and life science advertising

Since April 2020, as part of its efforts to address the covid-19 pandemic, the Russia Patent and Trademark Office (Rospatent) has introduced faster prosecution for patent applications for viruses...

Goltsblat BLP advises that the Telemedicine Law has been signed by the Russian President. Its purpose is to establish a legal framework for using telemedicine technologies in Russia...

The RF Government will detail the specifications for these identifiers and the process for putting them on packaging in a separate document.

A reservation taking these powers away from Minselkhoz will also be incorporated into the Regulation on the Ministry of Agriculture of the Russian Federation.

Специалисты GRATA International в области Фармацевтики и здравоохранения выпустили новую публик

The Federal Law No. 241-FZ dated 13 July 2015 (hereinafter - the Law 241) introduced amendments to the Federal Law No. 61-FZ dated 12 April 2010 'On The Medicines Circulation' (hereinafter - the 'Circulation Law'), as well as to the Federal Law, dated 22 December 2014 No. 429-FZ (which had significantly amended the Circulation Law with the effect from 1 July 2015).

Russia's Law on the Circulation of Medicines is probably one of the country's most frequently amended laws - and certainly one of its most debated.

AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them against encroachers.

Federal State Enterprise "SHCHELKOVO BIOCOMBINAT" (SCHBK) is the largest domestic enterprise specializing in the production and supply of biotechnologies and veterinary drugs.

On September 5, 2018, the RF Government issued Executive Order No. 1851-r, which put before the State Duma a bill of amendments

As in most European countries – where the respective national patent system coexists with a wider European system – the national patent system in Russia coexists with the Eurasian patent system...

The Law on the Introduction of Amendments to Certain RF Laws Concerning the Prevention and Liquidation of Emergency Situations has now come into force,...

On October 1, 2015, the new versions of the following regulations will come into legal force and effect: